|Bid||2.4300 x 0|
|Ask||2.4400 x 0|
|Day's Range||2.4300 - 2.6300|
|52 Week Range||2.1900 - 10.2400|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 14, 2019 - May 15, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||5.23|
Toronto, Ontario--(Newsfile Corp. - September 16, 2019) - Capital 10X announces the release of an Initiation Report on the Organic Cannabis Market that features The Green Organic Dutchman among other organic cannabis producers. Cannot view this video? Visit:https://capital10x.com/initiation-organic-cannabis-market/Executive SummaryThe global market for organic products is currently worth $160 billion and is forecast to grow to $323 billion by 2024, a 15% annual growth rate. Organic sales have been strong for decades growing at ...
TORONTO , Sept. 12, 2019 /CNW/ - The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TGOD.TO) (TGODF), a leading producer of premium certified organic cannabis, is pleased to announce that following its launch in Ontario at the end of August, which marked the Company's entrance into Canada's recreational market, initial demand has exceeded expectations. TGOD's high-THC signature strain, Unite Organic, is performing well online and at dispensaries, triggering a second order from the OCS earlier than initially anticipated.
Aurora Cannabis (NYSE:ACB) stock will report its earnings on Thursday before the opening bell. Investors will closely watch Aurora Cannabis stock for guidance amid its decline and that of its peers.Source: Shutterstock Yes, some of the stock decreases came when peers such as Canopy Growth (NYSE:CGC) and Tilray (NASDAQ:TLRY) issued their reports. Still, ACB stock faces its own test. Although Aurora should continue to lead the world in marijuana production, size alone will not make ACB a buy going into earnings. Q2 Expectations and ACB StockFor the second quarter, analysts expect a loss of five Canadian cents (3.8 cents) per share. The company reported losses of 15 Canadian cents per share in the same quarter last year. However, investors should note that Aurora has missed estimates in three of the previous four quarterly reports.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 10 Stocks to Sell in Market-Cursed September They also predicted revenues of C$258.95 million ($196.71 million). If this holds, it will represent a 369.1% increase in revenues year-over-year. ACB brought in revenues of C$55.2 million in the second quarter of 2018.Despite the massive increase in revenue, the only likely source of profit for Aurora Cannabis will come from stock trading. The company recently sold its 10.5% stake in The Green Organic Dutchman Holdings (OTCMKTS:TGODF).This nets the company $86.5 million. As our own James Brumley states, the deal could buy C$86.5 million ($65.71 million) worth of time to generate profits. It could also help with debt relief as the company has to pay back C$230 million worth of debt on March 9, 2020. Outstanding Shares and Aurora Cannabis StockAnother key component that should garner investor interest involves the shares outstanding on Aurora Cannabis stock. In previous articles, I have remained bearish on ACB stock for the massive amount of dilution. About 129 million shares existed in 2016. Today that figure now exceeds one billion.In a sense, I do not blame the company for diluting the stock. The market's toleration for high multiples seems to have fallen. Despite an ACB stock price of around $6 per share, the equity still trades at about 43.7 times sales.While Aurora continues to lose money, it makes sense from a company perspective to issue more shares. However, with that level of dilution, it leaves investors with no good reason to pay nearly 44 times sales for the stock. Other dangers for Aurora Cannabis StockThis situation could also lead to something unthinkable for a world leader in marijuana production--a reverse stock split. The average price-to-sales (PS) ratio for the S&P 500 stands at 1.53. Even if ACB stock fell to a PS ratio of 4.37 under current revenue figures, that would take ACB to about 60 cents per share.A reverse split means little in a financial sense, and I believe revenue growth will reduce the PS ratio over time. Still, it would represent a huge psychological blow if it needed to make such a move to escape penny stock status.James Brumley makes another critical point. Companies such as sit on billions in goodwill from various acquisitions. Aurora itself paid C$3.2 billion ($2.43 billion) to purchase MedReLeaf. A forced write-down of this purchase and comparable takeovers by peers could hurt stocks across the industry. This could have also played a role in Aurora's sale of TGODF stock. Final thoughts on ACB stockUnder current conditions, the company earnings report will likely leave investors with little reason to own Aurora Cannabis stock. Aurora Cannabis remains a world leader in the production of marijuana. Even if the company falls short of earnings estimates again, I see little that should threaten this leadership change.However, investors need to separate Aurora Cannabis from Aurora Cannabis stock. Given the elevated multiple, Aurora has supported itself and funded acquisitions in large measure from massive stock dilution. Despite the proceeds from selling its stake in the Green Organic Dutchman, the company still needs cash to fund operations and pay debts. As long as this practice continues, I see little reason to own ACB stock.As I have stated before, profiting from Aurora Cannabis stock long term will only happen when the company transforms itself. When it becomes profitable and pays dividends like Altria (NYSE:MO), investors can more reliably earn positive returns from the Aurora story.Unfortunately, today's Aurora Cannabis could easily face write-downs and possible a reverse stock split. With continuing losses, stock dilution, and earnings misses, investors have little incentive to pay almost 44 times sales for such an equity, before or after the earnings release.As of this writing, Will Healy did not hold a position in any of the aforementioned stocks. You can follow Will on Twitter at @HealyWriting. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Stocks to Sell in Market-Cursed September * 7 of the Worst IPO Stocks in 2019 * 7 Best Stocks That Crushed It This Earnings Season The post Avoid Aurora Cannabis Stock, Both Before and After Earnings appeared first on InvestorPlace.
The Green Organic Dutchman Holdings Ltd (TSX: TGOD) (US: TGODF ) and water-soluble cannabinoid producer Caliper Foods announced Monday the results of a preliminary human pharmacokinetic study of Caliper ...
Higher cannabinoid absorption was observed for Caliper CBD within 15 minutes compared to the maximum absorption of CBD in oil in 45 minutes. TORONTO and DENVER , Sept. 9, 2019 /CNW/ - The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TGOD.TO) (TGODF), a leading producer of premium certified organic cannabis, and Caliper Foods (formerly Stillwater Foods), a best-in-class provider of water-soluble cannabinoid products, are pleased to unveil the results of a preliminary human pharmacokinetic ("PK") study of Caliper CBD, Caliper Foods' proprietary tasteless and odourless water-soluble powder that can be added to almost any food or beverage.
Aurora Cannabis (NYSE:ACB) announced September 4 that it sold its 10.5% stake in Green Organic Dutchman Holdings (OTCMKTS:TGODF) for gross proceeds of CAD $86.5 million or CAD $3 a share. Owners of Aurora Cannabis stock will be pleased to learn the sale resulted in a 50% internal rate of return. Source: Shutterstock In addition, it still holds warrants to buy another 16,666,667 shares of TGODF that are exercisable at $3 share. With the stock currently trading around $3, it's going to be a while before ACB could cash in those warrants. In the meantime, Aurora has more than $40 million in pre-tax profits to put to work. Here's where I think the owners of ACB stock will get the most bang for their buck.InvestorPlace - Stock Market News, Stock Advice & Trading Tips These Pretzels Are Making Me ThirstyI couldn't resist the Seinfeld reference but the one area where Aurora has been slow to the party is in the cannabis-infused drinks market. * 7 Stocks to Buy In a Flat Market Sure, it won't be able to legally sell these drinks in its Canadian home market until mid-December of this year, but that's left it with plenty of time to organize a game plan for the drinks market. It's disappointing that it hasn't.Instead, Aurora is going to focus on vape pens and concentrates for its growth beyond the dried flower. "You're going to start seeing people shift over from the illicit market, the minute vape pens become available. And we have a head start on that," Aurora Chief Corporate Officer Cam Battley said in June. Given the recent health concerns about vaping that have cropped up in 16 U.S. states suggests that the failure to have a backup plan could hurt Aurora in the near term. Long term, I'm sure the vaping issues will get sorted, but there is definitely more investigation to be done. However, Aurora's lack of cannabis-infused drinks is a big reason why I'm (pardon the pun) high on both Canopy Growth (NYSE:CGC) and Hexo (NYSE:HEXO), whose Big Alcohol partners bring knowledge and distribution capabilities to the table, making them attractive cannabis investments in my opinion. Don't get me wrong. There's a lot to like about Aurora. Here's what I said about it in August:"Aurora Cannabis continues to use its industry-leading size in both Canada and abroad to capture a big part of the global cannabis market. The fact that it doesn't have a U.S. business plan at the moment doesn't mean it won't enter the market in the future.""Furthermore, while it doesn't have a huge strategic partner, if it continues to implement innovative ideas such as cultivating outside, I don't think it will have a problem attracting a huge strategic investor." Why Not Partner With Coke?Back in 2018, Aurora held talks with Coca-Cola (NYSE:KO) but those seemed to have fizzled out. However, the fact that it recruited billionaire Nelson Peltz, whose Trian Fund Management has several high-profile consumer goods investments, to help guide the company through its ongoing growth suggests that it might reconsider a partnership with a company such as Coke in the future. In my opinion, the owners of Aurora Cannabis stock would be well served by the company reconsidering its stance on cannabis-infused drinks. I can say with certainty that my age group (mid-50s) are far more inclined to try THC/CBD drinks or edibles than they are vapes or dried flower. If you haven't smoked cigarettes your entire life or for many years, why would you start with weed? You wouldn't. The Bottom Line on Aurora StockYou can't be all things to all people. That I get. So, it makes sense that Aurora's focused its efforts on products that have done well in the U.S. states where recreational pot is legal. However, tastes can change. Few have delivered cannabis-infused drinks that taste good. If Canopy or Hexo can break through that barrier, I'm confident they'll roll those drinks out across the U.S. as more states and the feds legalize pot. * 7 Triple Threat Growth Stocks to Buy for the Long Term In the meantime, all Aurora can do is hope that they don't. A better plan would be to join the party. It's got 40 million reasons to do so. At the time of this writing Will Ashworth did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Deeply Discounted Energy Stocks to Buy * 7 Stocks to Buy In a Flat Market * 10 Stocks to Buy to Ride China's Emerging Wealth The post Aurora Cannabis Should Spend Latest Cash Infusion on Infusions of Its Own appeared first on InvestorPlace.
Aphria (TSX: APHA) (NYSE: APHA) has filed its annual report for the fiscal year ended May 31 on Form 40-F with the U.S. Securities and Exchange Commission. Aphria is a global cannabis company headquartered in Leamington, Ontario. SOL Global Investments (CSE: SOL) (OTCPK: SOLCF) (Frankfurt: 9SB) has announced that Andy DeFrancesco will step down from his role as chief […]The post Cannabis Stock News Daily Roundup September 5 appeared first on Market Exclusive.
August was a nasty month for the marijuana sector. It had its share of bad news, the crushing oversupply continued to mount in the Canadian market, and marijuana stock prices slumped all month. Traders are hoping that September will prove more prosperous. There are some reasons for hope on that front. Tilray (NASDAQ:TLRY), for example, started the month with a 17% jump on Tuesday.So where does Aurora Cannabis (NYSE:ACB) stock fit into the picture? As long-time readers know, I've been negative on the marijuana space for a long time now. Primarily, I don't like the huge oversupply in the Canadian market. Every month, Health Canada publishes more and more discouraging supply and demand figures for the recreational market. In both dried cannabis and CBD, the available product greatly exceeds customer demand.InvestorPlace - Stock Market News, Stock Advice & Trading Tips Aurora Cannabis Dumps The Green Organic DutchmanAurora Cannabis started September on an interesting note. That's because The Green Organic Dutchman Holdings (OTCMKTS:TGODF) or "TGOD" announced a sizable share offering at 3 CAD. That was a discount from the 3.51 CAD closing price Tuesday for TGODF stock. The TGOD stock offering serves the sole purpose of allowing Aurora Cannabis to dump its position in TGOD and raise cash.This equity offering should remind investors of two things. One, marijuana companies are continuing to burn through tons of cash and need to raise more of it. And two, make sure you are comfortable with the companies you own. I say that because there will be more excitement ahead, even after this crushing sector selloff. Aurora Is Making the Right MoveInvestors have had mixed feelings about Aurora's involvement with The Green Organic Dutchman for a while. But I give management credit for a well-played trade. In fact, it served as a shrewd investment. * 7 Deeply Discounted Energy Stocks to Buy In early 2018, Aurora Cannabis acquired a substantial chunk of TGOD for just 1.65 CAD per share. It ultimately purchased a little more at higher prices. But on net, Aurora cleaned up on the transaction. It sold off some TGOD stock over the past 12 months at attractive prices. It's now unloading the rest at 3 CAD for nearly double of their original cost basis.In 2019, TGOD stock has traded consistently below 5 CAD. Plus, the price is still well above where it bottomed at the end of last year. Thus, Aurora is unloading its stock at a favorable price, at least in comparison to other more beaten-up marijuana equities.Let's face it: given current conditions in the marijuana industry, it's much better to have cash on your balance sheet than in the form of stock at a company that is still in the early stages of commercializing its business.TGOD has failed to reach significant revenues while most of the industry has already hit that point. Further, critics question the management team's ability to deliver on its stated goals. Perhaps with that in mind, Aurora pivoted and went in a different direction.Rather than investing further in TGOD when it had the opportunity, Aurora instead purchased Whistler Medical Marijuana for 175 million CAD. This gave Aurora Cannabis access to 100% organic marijuana supplies without having to rely on its slow-to-production TGOD partner. Who knows, Aurora may even use cash from its successful TGOD stock investment to help fund further development of its competing products at Whistler. TGOD Deal Adds More Intrigue to Upcoming EarningsIt will be interesting to see if Aurora has any more surprises coming up with their earnings announcement. As I detailed recently, Aurora pulled ahead of its peers by offering an early taste of its quarterly results, which are due out next week. Aurora said that revenues for the quarter will come in strong. That's despite the general weakness that many other cannabis companies have reported so far this earnings cycle.And now we have this TGOD divestiture as well. Remember that Aurora already had a decent cash balance. As of March 31, Aurora had 391 million CAD (nearly $300 million) in cash on its balance sheet. It's likely used a fair chunk of that in operations and growth expenses since then. Still, ACB stock is associated to a reasonably well-positioned treasury.Thus, it adds mystery to the timing of the TGOD stock sale. Is Aurora about to make another big acquisition? Will management announce a large new growth initiative? Did something go wrong with operations, causing them to want to raise capital from the TGOD sale at this time? Or will they simply let the cash sit on their balance sheet for a while? The Verdict on ACB StockIt's hard to get excited about any of these marijuana stocks right now with the industry facing such drastic oversupply. That said, these investments are deeply oversold. And at some point, they simply have to bounce back, at least in the short run. If you're looking for such a bounce trade, Aurora Cannabis stock looks intriguing.ACB stock - based on its U.S. listing - has strong support at the $5 level. With shares trading around $5.60 now, that limits your downside if support holds.Meanwhile, Aurora Cannabis stock could jump sharply once that support holds and buyers come back into the picture. If you're looking for a catalyst, let's see what happens with that upcoming earnings report. As additional cash comes in from the TGOD sale, ACB stock may be ready for another big move.At the time of this writing, Ian Bezek held no positions in any of the aforementioned securities. You can reach him on Twitter at @irbezek. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Deeply Discounted Energy Stocks to Buy * 7 Stocks to Buy In a Flat Market * 10 Stocks to Buy to Ride China's Emerging Wealth The post Aurora Cannabis Dumps Green Organic Dutchman Stake Ahead of Earnings appeared first on InvestorPlace.
After Aurora Cannabis (NYSE:ACB) sold its remaining 10.5% stake in cannabis supplier Green Organic Dutchman Holdings (OTCMKTS:TGODF) ACB stock was up, but only for a short while. Given time to think about it, traders ultimately decided Aurora Cannabis stock wouldn't be worth any more without than with it.They may be right.InvestorPlace - Stock Market News, Stock Advice & Trading TipsGranted, the sale nets Aurora a hefty $86.5 million in cash. That may be a modest figure compared to its market cap of $5.7 billion, but will prove a meaningful boost to however much of the unrestricted cash hoard of $346.7 million was left on the books as of the end of March.It also buys Aurora Cannabis $86.5 million worth of time to figure out how to turn revenue into more profits. It and rivals like Aphria (NYSE:APHA) and Tilray (NASDAQ:TLRY) have been reporting negative cash flow of late, hinting at a looming cash crunch that could up-end these organizations before they work their way out of the red.The decision to scale out of the rest of Green Organic Dutchman, though, may ultimately be a subtle hint that all the aggressive cannabis dealmaking of the past several months isn't panning out. A Bad Buy and ACB StockMost Aurora Cannabis stock owners may not even realize it, but the company was a key supporter of Green Organic Dutchman Holdings even before Green Organic Dutchman Holdings went public. * 7 Deeply Discounted Energy Stocks to Buy Aurora purchased roughly 33 million shares of TGOD in January of last year, and added 6.3 million IPO shares in May of last year, paying $3.65 each.The funding also granted Aurora the option of buying nearly 17 million more shares in the future, at $3.00 apiece.The investment wasn't really about speculating on another young player in the cannabis business though. Aurora Cannabis was willing to hand over tens of millions of dollars of its own in order to secure the rights to purchase 20% of Green Organic Dutchman's cannabis production.That's where things went south.Green Organic Dutchman Holdings has struggled to produce at the levels it was suggesting it would be able to yield a year ago. For example, the completion of its Hamilton and Valleyfield facilities was pushed back from the final quarter of last year to the middle of this year, though that's not the only way the company has come up short.It was the worst possible time to not deliver, as retailers jockey for market share.In the meantime, Aurora Cannabis sought out and found alternatives. CEO Terry Booth wasn't afraid to explain exactly how and why either, commenting in Wednesday's news release:"When we acquired Whistler Medical Marijuana Corporation - an iconic and premium organic cannabis producer - our interest in TGOD became less important to our core strategy. Our return on our TGOD investment is significant and will add non-dilutive capital and further enhance our strategy to remain a dominant force in the global cannabis industry."Lauding one partner over the other and saying the words "our interest in TGOD became less important to our core strategy" cuts straight to the heart of the matter, stopping just short of saying something along the lines of "Green Organic Dutchman wasn't getting the job done." ACB Stock Price Is VulnerableAurora Cannabis was fortunate it was able to record a gain on its partnership-driven investment in TGOD. Rival cannabis names haven't been as lucky.Case in point: TILT Holdings (OTCMKTS:SVVTF) reported an impairment charge of half a billion dollars in May, stemming from a lackluster return on an investment it made in an effort to grow and create some synergy. Aphria has also been forced to write down $50 million worth of soured acquisitions.Aurora Cannabis is hardly immune to the prospect though, leaving the ACB stock price vulnerable to even more weakness if-and-when shareholders are forced to digest such headlines.Indeed, in July, Bloomberg's Kenneth Shea pegged ACB stock as one of the names most vulnerable to writedowns along with Aphria and Canopy Growth (NYSE:CGC).All told, those three companies (and Tilray and Cronos Group (NASDAQ:CRON) as well) are collectively sitting on $4 billion worth of goodwill related to spending on previous acquisitions. If those don't start to bear fruit soon, these players will be forced to book writedowns on their respective goodwill tallies.Its Green Organic Dutchman Holdings isn't part of $3.2 billion worth of goodwill on Aurora's books. But, the decision to cull its stake and supplant the partnership with another supplier is still telling in and of itself. It says not every partnership is paying off as anticipated. Looking Ahead for ACB StockIt's dangerous to draw sweeping conclusions just from one single event, but you have to wonder about ACB stock here.On the flip side, it's naive to ignore a possibility when it jibes with other related developments. Aurora has clearly rethought Green Organic Dutchman, but it's also rethought its Australis Capital subsidiary. Both were businesses the company wanted to be in not too long ago.Meanwhile, Terra Tech (OTCMKTS:TRTC) has shed its Reno dispensary, and hedge funds couldn't cut loose of key cannabis stocks fast enough during the second quarter, before things turned really ugly.In short, cannabis players are changing their minds about a great number of things, after being in the business for a while.To that end, it would be short-sighted to think the two aforementioned ventures are the only two that have fallen short of Aurora's expectations. They're just packaged differently than others.Whatever is in the cards, a good deal of it should come to light after the closing bell rings on Wednesday, Sept. 11. That's when the company will reveal its fiscal Q4 numbers, followed by an earnings conference call the following morning.As was the case with other cannabis names, current and prospective Aurora Cannabis stockholders will be looking to see if the quarter ending in June will be the beginning of a writedown spree.Shedding its stake in Green Organic Dutchman ups the odds it will be.As of this writing, James Brumley held no position in any of the aforementioned securities. You can learn more about James at his site, jamesbrumley.com, or follow him on Twitter, at @jbrumley. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Deeply Discounted Energy Stocks to Buy * 7 Stocks to Buy In a Flat Market * 10 Stocks to Buy to Ride China's Emerging Wealth The post Dumping Acquisitions Could Signal More Bad News for ACB Stock appeared first on InvestorPlace.
TORONTO, Sept. 4, 2019 /PRNewswire/ - The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TSX:TGOD) (TGODF) comments on the recent transaction between Aurora Cannabis ("Aurora") (TSX:ACB) and a syndicate of Canadian banks. The block trade was executed on September 3 after market close. A total of 28.8 million shares were exchanged at a negotiated price of $3.00 per unit. The Edmonton-based company still retains a large number of TGOD warrants equivalent to approximately 5% of the Company's fully diluted shares.
TORONTO, Sept. 3, 2019 /PRNewswire/ - The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TGOD.TO) (TGODF), a leading producer of premium certified organic cannabis, is pleased to announce that it has obtained approval from Health Canada, under the Cannabis Regulations, to expand operations into its new hybrid greenhouse located in Hamilton, Ontario. The 123,000 square foot state-of-the-art facility will serve to increase TGOD's premium organic cannabis production as it expands its sales in Canada.
The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (US: TGODF), a producer of premium certified organic cannabis, has completed its inaugural shipment to the Ontario Cannabis Store. This marks the company’s entrance into Canada's recreational market. Soon, Ontario consumers will be able to experience TGOD's Unite Organic dried flower, the company's high THC signature strain. […]The post Green Organic Dutchman Enters Canada's Recreational Cannabis Market appeared first on Market Exclusive.
TORONTO, Aug. 16, 2019 /PRNewswire/ - The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TGOD.TO) (TGODF), a leading producer of premium certified organic cannabis, is pleased to announce that it has completed its inaugural shipment to the Ontario Cannabis Store, marking the Company's entrance into Canada's recreational market. Ontario consumers will soon be able to experience TGOD's acclaimed Unite Organic dried flower, the Company's high THC signature strain, which will be available on www.ocs.ca as well as at select retail locations across the province.
TORONTO , Aug. 13, 2019 /CNW/ - The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TGOD.TO) (TGODF) is pleased to report its financial and operational results for the three and six months ended June 30, 2019 . In Canada , the Company launched its pilot "Grower's Circle", which included sales to a small number of medical patients to test the market and the Company's distribution capabilities. The Company launched two new products in Q2 and expects to start a similar pilot in the Ontario recreational market during Q3-2019.
The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (US: TGODF) announced that it has renewed its Health Canada licenses for the company's facility in Ancaster, Ontario. The stock closed at the highs of the week on Friday. TGOD has renewed the licenses until August 2022. The licenses authorize the company to cultivate, process and sell […]The post Green Organic Dutchman Stock Soars After License Renewal Announcement appeared first on Market Exclusive.
TORONTO , Aug. 6, 2019 /PRNewswire/ - The Green Organic Dutchman Holdings Ltd. ("TGOD" or the "Company") (TSX: TGOD) (US: TGODF) announced today that the Company expects to release ...